Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan

被引：2
|
作者：
Aqeel, Faten [1 ]
Zonozi, Reza [2 ,3 ]
Jeyabalan, Anushya [2 ,3 ]
Sauvage, Gabriel [4 ]
Niles, John L. [4 ]
Geetha, Duvuru [1 ]
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
[2] Massachusetts Gen Hosp, Vasculitis & Glomerulonephritis Ctr, Div Nephrol, Boston, MA 02114 USA
[3] Harvard Med Sch, Dept Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
来源：
RMD OPEN | 2023年 / 9卷 / 03期
关键词：
COVID-19; Systemic vasculitis; Vaccination;
D O I：
10.1136/rmdopen-2023-003435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Avacopan as a new therapeutic option in ANCA-associated vasculitis
    Lobenwein, Corinna
    Wilde, Benjamin
    NEPHROLOGE, 2022, 17 (03): : 193 - 196
  • [32] Avacopan offers alternative to steroids for ANCA-associated vasculitis
    Sarah Onuora
    Nature Reviews Rheumatology, 2021, 17 : 249 - 249
  • [33] Avacopan as a new therapeutic option in ANCA-associated vasculitis
    Lobenwein, Corinna
    Wilde, Benjami
    NEPHROLOGIE, 2022, 17 (03): : 193 - 195
  • [34] Avacopan offers alternative to steroids for ANCA-associated vasculitis
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (05) : 249 - 249
  • [35] COVID-19 IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS
    Hocevar, A.
    Burja, B.
    Tomsic, M.
    Rotar, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1662 - 1662
  • [36] INCIDENCE AND OUTCOME OF COVID-19 IN ANCA-ASSOCIATED VASCULITIS: IMPACT OF COVID-19 IN PATIENTS UNDERGOING RITUXIMAB FOR MAINTENANCE
    Treppo, E.
    Binutti, M.
    Del Frate, G.
    De Vita, S.
    Quartuccio, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 883 - 883
  • [37] TREATMENT WITH AVACOPAN FOR ANCA-ASSOCIATED VASCULITIS WITH DIFFUSE ALVEOLAR HEMORRHAGE
    Falde, Samuel D.
    Lal, Amos
    Cartin-Ceba, Rodrigo
    Mertz, Lester
    Lee, Augustine S.
    Specks, Ulrich
    CHEST, 2023, 164 (04) : 3067A - 3068A
  • [38] Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis
    Antovic, A.
    Bruchfeld, A.
    Ekland, J.
    Lovstrom, B.
    Hugelius, A.
    Borjesson, O.
    Knight, A.
    Gunnarsson, I
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (04) : 418 - 423
  • [39] Pediatric ANCA-Associated Vasculitis Case Series: Is It Covid-19 Related?
    Goknar, Nilufer
    Ozturk, Kubra
    Girit, Saniye
    Amiraslanova, Nazire Dostuyeva
    Sen Duman, Zulal
    Celikel, Kardelen
    Ozkanli, Seyma
    Haslak, Fatih
    Candan, Cengiz
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S242 - S243
  • [40] Avacopan for the treatment of ANCA-associated vasculitis: an update (vol 19, pg 461, 2023)
    Osman, M.
    Tervaert, J. W. C.
    Pagnoux, C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 321 - 321
12345